TY - JOUR
T1 - Clinical and surgical predictors of complications following surgery for the treatment of cervical spondylotic myelopathy
T2 - results from the multicenter, prospective AOSpine international study of 479 patients
AU - Tetreault, Lindsay
AU - Tan, Gamaliel
AU - Kopjar, Branko
AU - Côté, Pierre
AU - Arnold, Paul
AU - Nugaeva, Natalia
AU - Barbagallo, Giuseppe
AU - Fehlings, Michael G.
N1 - Publisher Copyright:
© 2015 by the Congress of Neurological Surgeons.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - BACKGROUND: Surgery for cervical spondylotic myelopathy (CSM) is generally safe and effective. Nonetheless, complications occur in 11% to 38% of patients. Knowledge of important predictors of complications will help clinicians identify high-risk patients and institute prevention and management strategies. OBJECTIVE: To identify clinical and surgical predictors of perioperative complications in CSM patients. METHODS: Four hundred seventy-nine surgical CSM patients were enrolled in the prospective CSM-International study at 16 sites. A panel of physicians reviewed all adverse events and classified each as related or unrelated to surgery. Univariate analyses were performed to determine differences between patients who experienced a perioperative complication and those who did not. A complication prediction rule was developed using multiple logistic regression. RESULTS: Seventy-eight patients experienced 89 perioperative complications (16.25%). On univariate analysis, the major clinical risk factors were ossification of the posterior longitudinal ligament (OPLL) (P .055), number of comorbidities (P .002), comorbidity score (P .006), diabetes mellitus (P .001), and coexisting gastrointestinal (P .039) and cardiovascular (P .046) disorders. Patients undergoing a 2-stage surgery (P .002) and those with a longer operative duration (P .001) were at greater risk of perioperative complications. A final prediction model consisted of diabetes mellitus (odds ratio [OR] 1.96, P .060), number of comorbidities (OR 1.20, P .069), operative duration (OR 1.07, P .002), and OPLL (OR 1.75, P .040). CONCLUSION: Surgical CSM patients have a higher risk of perioperative complications if they have a greater number of comorbidities, coexisting diabetes mellitus, OPLL, and a longer operative duration. Surgeons can use this information to discuss the risks and benefits of surgery with patients, to plan case-specific preventive strategies, and to ensure appropriate management in the perioperative period.
AB - BACKGROUND: Surgery for cervical spondylotic myelopathy (CSM) is generally safe and effective. Nonetheless, complications occur in 11% to 38% of patients. Knowledge of important predictors of complications will help clinicians identify high-risk patients and institute prevention and management strategies. OBJECTIVE: To identify clinical and surgical predictors of perioperative complications in CSM patients. METHODS: Four hundred seventy-nine surgical CSM patients were enrolled in the prospective CSM-International study at 16 sites. A panel of physicians reviewed all adverse events and classified each as related or unrelated to surgery. Univariate analyses were performed to determine differences between patients who experienced a perioperative complication and those who did not. A complication prediction rule was developed using multiple logistic regression. RESULTS: Seventy-eight patients experienced 89 perioperative complications (16.25%). On univariate analysis, the major clinical risk factors were ossification of the posterior longitudinal ligament (OPLL) (P .055), number of comorbidities (P .002), comorbidity score (P .006), diabetes mellitus (P .001), and coexisting gastrointestinal (P .039) and cardiovascular (P .046) disorders. Patients undergoing a 2-stage surgery (P .002) and those with a longer operative duration (P .001) were at greater risk of perioperative complications. A final prediction model consisted of diabetes mellitus (odds ratio [OR] 1.96, P .060), number of comorbidities (OR 1.20, P .069), operative duration (OR 1.07, P .002), and OPLL (OR 1.75, P .040). CONCLUSION: Surgical CSM patients have a higher risk of perioperative complications if they have a greater number of comorbidities, coexisting diabetes mellitus, OPLL, and a longer operative duration. Surgeons can use this information to discuss the risks and benefits of surgery with patients, to plan case-specific preventive strategies, and to ensure appropriate management in the perioperative period.
KW - Cervical spondylotic myelopathy
KW - Complications
KW - Perioperative
KW - Prediction
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=84949058261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84949058261&partnerID=8YFLogxK
U2 - 10.1227/NEU.0000000000001151
DO - 10.1227/NEU.0000000000001151
M3 - Article
C2 - 26619333
AN - SCOPUS:84949058261
SN - 0148-396X
VL - 79
SP - 33
EP - 43
JO - Neurosurgery
JF - Neurosurgery
IS - 1
ER -